Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 9041-9050 of 13616

Page
per page
  1. Efavirenz
    B1119 Efavirenz
    Target: HIV-1 reverse transcriptase
    Summary: Reverse transcriptase inhibitor
      insoluble in H2O; ≥15.55 mg/mL
  2. Sitaxentan sodium
    B1522 Sitaxentan sodium
    Summary: Selective endothelin A receptor (ETA) antagonist
      ≥23.84 mg/mL
  3. VU661013
    A8783 VU661013
    Summary: Novel, potent, selective MCL-1 inhibitor
      ≥125 mg/mL
  4. BAY1895344 HCl
    B8451 BAY1895344 HCl
    Summary: A highly selective ATM inhibitor for tumor therapy and combination treatment
  5. BVT 2733
    B6104 BVT 2733
    Summary: 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor
      ≥42.9 mg/mL
  6. PBIT
    C3584 PBIT
    Summary: JARID1 family demethylases inhibitor
      ≤1 mg/mL
  7. CEP-28122
    C4025 CEP-28122
    Summary: anaplastic lymphoma kinase (ALK) inhibitor
      ≤30 mg/mL
  8. NQTrp
    C4194 NQTrp
    Summary: inhibitor of Alzheimer’s disease-associated amyloid β (Aβ) oligomerization and fibrillization
      ≤1 mg/mL
  9. OU749
    C4135 OU749
    Summary: γ-Glutamyl transferase (GGT) inhibitor
      ≤5 mg/mL
  10. MMP-13 Inhibitor
    C4331 MMP-13 Inhibitor
    Summary: MMP-13 inhibitor
      ≤0.5 mg/mL

Items 9041-9050 of 13616

Page
per page